SHREE GANESH REMEDIES
Back to All Ratios
|
SHREE GANESH REMEDIES Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2020 | Mar2019 | |
---|---|---|---|
EV/EBIT(x) | 22.62 | 4.75 | 5.45 |
What is the latest EV/EBIT ratio of SHREE GANESH REMEDIES ?
Year | EV/EBIT |
---|---|
Mar2024 | 22.62 |
Mar2020 | 4.75 |
Mar2019 | 5.45 |
How is EV/EBIT of SHREE GANESH REMEDIES Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 22.62 | 376.21 | |
Mar2020 | 4.75 | -12.84 | |
Mar2019 | 5.45 | - |
Other Financial Ratios of SHREE GANESH REMEDIES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of SHREE GANESH REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SHREE GANESH REMEDIES | ₹916.6 Cr | 1.8% | -19.8% | -1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,277.0 Cr | 1.3% | -8.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,802.0 Cr | 1.6% | -8.6% | 57.3% | Stock Analytics | |
CIPLA | ₹118,061.0 Cr | 3.6% | 0.9% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,519.0 Cr | 3.9% | -1.5% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,026.5 Cr | 1.9% | -6.6% | -9.8% | Stock Analytics |
SHREE GANESH REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SHREE GANESH REMEDIES | 1.8% |
-19.8% |
-1% |
SENSEX | -0.4% |
-3.7% |
0.8% |
You may also like the below Video Courses